Opaleye Management Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 118 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$5,740,000
-30.9%
500,000
+2.0%
2.14%
+1.4%
Q3 2018$8,305,000
+15.8%
490,000
-3.0%
2.11%
+13.8%
Q2 2018$7,171,000
-29.5%
505,000
-5.6%
1.86%
-36.1%
Q1 2018$10,165,000
+6.9%
535,000
-7.8%
2.91%
-4.6%
Q4 2017$9,512,000
+9.3%
580,0000.0%3.05%
-1.0%
Q3 2017$8,700,000
+70.5%
580,0000.0%3.08%
+44.3%
Q2 2017$5,104,000
+69.0%
580,000
-0.2%
2.13%
+41.8%
Q1 2017$3,021,000
+147.6%
581,000
+45.2%
1.50%
+109.2%
Q4 2016$1,220,000
+122.6%
400,000
+566.7%
0.72%
+214.0%
Q4 2015$548,00060,0000.23%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,032,980$12,950,0001.82%
EcoR1 Capital, LLC 2,308,079$14,702,0001.54%
Alexandria Capital, LLC 1,005,119$6,403,0001.05%
Casdin Capital, LLC 1,455,000$9,268,0000.98%
Rhenman & Partners Asset Management AB 700,000$4,459,0000.62%
Bellevue Group AG 3,850,000$24,525,0000.48%
GREAT POINT PARTNERS LLC 633,505$4,035,0000.42%
WASATCH ADVISORS LP 5,938,434$37,828,0000.39%
361 CAPITAL LLC 109,161$695,0000.32%
Ceeto Capital Group, LLC 50,000$319,0000.26%
View complete list of SANGAMO THERAPEUTICS INC shareholders